Media Nusantara Citra Tbk PT (MNCN)
Jakarta Exchange · Indonesia · prices in IDR · close of 20 Oct 2026
Key indicators
| Last close | IDR 85.00 |
|---|---|
| 52-week range | 85.00 – 302.00 |
| Return, 1 month / 3 months | −51.7% / −59.9% |
| Return, 1 year / 3 years | −68.5% / −83.3% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 46.7% |
| Worst drawdown (1 year) | -70.9% |
| Average daily value traded | 10,942.33M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Media Nusantara Citra is an Indonesian media company based in Jakarta. It runs free-to-air television networks and radio stations, publishes newspapers and magazines, and operates a pay-television platform. The company also produces its own programming, including news, entertainment and drama, which it supplies to its channels and other outlets. Its audiences are Indonesian viewers and listeners, and its advertising customers are brands and agencies that reach them through its broadcast, print and digital properties.
On this site Media Nusantara Citra Tbk PT appears as a stock on the Jakarta Exchange (Indonesia), code MNCN, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Media Nusantara Citra Tbk PT (MNCN) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 85.00 on 20 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 754 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 68.5% and over the last three months it fell 59.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -60.1% | ||
| From 52-week high | -70.9% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -59.9% | ||
| 6-month return | -66.0% | ||
| 12-month return, skipping the last month | -34.8% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -70.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 10,942.33M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −29.2% |
|---|---|
| 1 month | −51.7% |
| 3 months | −59.9% |
| 6 months | −66.0% |
| 1 year | −68.5% |
| 3 years | −83.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 167.68 / 213.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 9.10 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jul 2023 | IDR 5.0000 |
| 9 Sep 2021 | IDR 8.0000 |
| 3 Jul 2019 | IDR 15.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.